» Articles » PMID: 23417863

Reduction of Cardiomyocyte S-nitrosylation by S-nitrosoglutathione Reductase Protects Against Sepsis-induced Myocardial Depression

Abstract

Myocardial depression is an important contributor to morbidity and mortality in septic patients. Nitric oxide (NO) plays an important role in the development of septic cardiomyopathy, but also has protective effects. Recent evidence has indicated that NO exerts many of its downstream effects on the cardiovascular system via protein S-nitrosylation, which is negatively regulated by S-nitrosoglutathione reductase (GSNOR), an enzyme promoting denitrosylation. We tested the hypothesis that reducing cardiomyocyte S-nitrosylation by increasing GSNOR activity can improve myocardial dysfunction during sepsis. Therefore, we generated mice with a cardiomyocyte-specific overexpression of GSNOR (GSNOR-CMTg mice) and subjected them to endotoxic shock. Measurements of cardiac function in vivo and ex vivo showed that GSNOR-CMTg mice had a significantly improved cardiac function after lipopolysaccharide challenge (LPS, 50 mg/kg) compared with wild-type (WT) mice. Cardiomyocytes isolated from septic GSNOR-CMTg mice showed a corresponding improvement in contractility compared with WT cells. However, systolic Ca(2+) release was similarly depressed in both genotypes after LPS, indicating that GSNOR-CMTg cardiomyocytes have increased Ca(2+) sensitivity during sepsis. Parameters of inflammation were equally increased in LPS-treated hearts of both genotypes, and no compensatory changes in NO synthase expression levels were found in GSNOR-overexpressing hearts before or after LPS challenge. GSNOR overexpression however significantly reduced total cardiac protein S-nitrosylation during sepsis. Taken together, our results indicate that increasing the denitrosylation capacity of cardiomyocytes protects against sepsis-induced myocardial depression. Our findings suggest that specifically reducing protein S-nitrosylation during sepsis improves cardiac function by increasing cardiac myofilament sensitivity to Ca(2+).

Citing Articles

Cardiac-specific ITCH overexpression ameliorates septic cardiomyopathy inhibition of the NF-κB signaling pathway.

Saito Y, Otaki Y, Watanabe T, Tachibana S, Sato J, Kobayashi Y J Mol Cell Cardiol Plus. 2025; 2():100018.

PMID: 39802494 PMC: 11708253. DOI: 10.1016/j.jmccpl.2022.100018.


Clinical effects of dexmedetomidine on patients with sepsis and myocardial injury.

Si X, Huang Z, Pan Z Medicine (Baltimore). 2024; 103(43):e40257.

PMID: 39470486 PMC: 11521069. DOI: 10.1097/MD.0000000000040257.


Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway.

Yang B, Li T, Wang Z, Zhu Y, Niu K, Hu S Int J Biol Sci. 2024; 20(11):4314-4340.

PMID: 39247818 PMC: 11379065. DOI: 10.7150/ijbs.96489.


Class III Alcohol Dehydrogenase Plays a Key Role in the Onset of Alcohol-Related/-Associated Liver Disease as an S-Nitrosoglutathione Reductase in Mice.

Haseba T, Maruyama M, Akimoto T, Yamamoto I, Katsuyama M, Okuda T Int J Mol Sci. 2023; 24(15).

PMID: 37569481 PMC: 10419236. DOI: 10.3390/ijms241512102.


Moderate exercise-induced dynamics on key sepsis-associated signaling pathways in the liver.

Osuru H, Ikeda K, Atluri N, Thiele R Crit Care. 2023; 27(1):266.

PMID: 37407986 PMC: 10324277. DOI: 10.1186/s13054-023-04551-1.


References
1.
Ao X, Lehrer S . Phalloidin unzips nebulin from thin filaments in skeletal myofibrils. J Cell Sci. 1995; 108 ( Pt 11):3397-403. DOI: 10.1242/jcs.108.11.3397. View

2.
Dyson A, Bryan N, Fernandez B, Garcia-Saura M, Saijo F, Mongardon N . An integrated approach to assessing nitroso-redox balance in systemic inflammation. Free Radic Biol Med. 2011; 51(6):1137-45. DOI: 10.1016/j.freeradbiomed.2011.06.012. View

3.
McDonald T, Grinman M, Carthy C, Walley K . Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol Heart Circ Physiol. 2000; 279(5):H2053-61. DOI: 10.1152/ajpheart.2000.279.5.H2053. View

4.
Parrillo J . Pathogenetic mechanisms of septic shock. N Engl J Med. 1993; 328(20):1471-7. DOI: 10.1056/NEJM199305203282008. View

5.
Buchwalow I, Schulze W, Karczewski P, Kostic M, Wallukat G, Morwinski R . Inducible nitric oxide synthase in the myocard. Mol Cell Biochem. 2001; 217(1-2):73-82. DOI: 10.1023/a:1007286602865. View